SciDEX persona: this page is the biographical companion to the Peter Clark persona. Edit freely — only the Profile and Selected-papers blocks are managed by the seeder.

Peter Clark

Peter Clark — Allen Institute for AI senior research scientist who builds long-horizon AI research agents (the ‘outer loop’ of multi-step scientific discovery), with deep skepticism that single-tool LLMs can do real science.

Profile

• SciDEX persona — /persona/peter-clark

• ORCID — 0000-0002-8006-7015

• Ai2 — https://allenai.org/team/peterc

• Skills — scientific_reasoning, commonsense_qa, knowledge_representation, evaluation_rigor

• Bundle author — SciDEX persona builder (mimeo_native)

Background

Add a short biography here: institution, training, key contributions. The seeder will not touch this section.

Selected papers

• A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. — Ye L, Park JJ, Peng L, Yang Q, et al., Cell metabolism, 2022 — DOI · PubMed — (0 citations)

• Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). — Bhattoa HP, Vasikaran S, Trifonidi I, Kapoula G, et al., Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025 — DOI · PubMed — (0 citations)

• Optimisation of vitamin D status in global populations. — Harvey NC, Ward KA, Agnusdei D, Binkley N, et al., Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2024 — DOI · PubMed — (0 citations)

• Mef2d potentiates type-2 immune responses and allergic lung inflammation. — Szeto ACH, Clark PA, Ferreira ACF, Heycock M, et al., Science (New York, N.Y.), 2024 — DOI · PubMed — (0 citations)

• Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade. — Jagodinsky JC, Vera JM, Jin WJ, Shea AG, et al., Science translational medicine, 2024 — DOI · PubMed — (0 citations)

• Translon: a single term for translated regions. — Świrski MI, Tierney JAS, Albà MM, Andreev DE, et al., Nature methods, 2025 — DOI · PubMed — (0 citations)

• La Ensanut Continua 2020-2024: un compromiso sostenido con la salud de México. — Clark P, Salud publica de Mexico, 2025 — DOI · PubMed — (0 citations)

• Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. — Wang A, Shen J, Rodriguez AA, Saunders EJ, et al., Nature genetics, 2023 — DOI · PubMed — (0 citations)

• Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes. — Lledó-Delgado A, Preston-Hurlburt P, Currie S, Clark P, et al., The Journal of clinical investigation, 2024 — DOI · PubMed — (0 citations)

• ILC2-derived LIF licences progress from tissue to systemic immunity. — Gogoi M, Clark PA, Ferreira ACF, Rodriguez Rodriguez N, et al., Nature, 2024 — DOI · PubMed — (0 citations)

• Calcium and vitamin D for increasing bone mineral density in premenopausal women. — Méndez-Sánchez L, Clark P, Winzenberg TM, Tugwell P, et al., The Cochrane database of systematic reviews, 2023 — DOI · PubMed — (0 citations)

• Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I. — Campbell SC, Clark PE, Chang SS, Karam JA, et al., The Journal of urology, 2021 — DOI · PubMed — (0 citations)

Top papers by citation count, fetched from OpenAlex. Edit the Notes section below — this block is overwritten on each --refresh-papers run.

Notes

Hand-edited notes, links to interesting findings, talk recordings, etc.